SMARCA2 and adenocarcinoma: Depletion of SMARCA4, but not of SMARCA2, significantly reduced proliferation of the adenocarcinoma cell line LNCaP and the LNCaP-derived androgen-independent CRPC-Adeno cell line C4-2 (Fig. 2f), in line with previous findings33,34.